Randomized Controlled Trial of Moderate-Intensity Rosuvastatin With Ezetimibe Combination Therapy Versus High-Intensity Rosuvastatin on Progression of Coronary Atherosclerotic Plaque
Clinical trial NCT03169985 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03169985
- Sponsor
- Samsung Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-12
- Primary completion
- 2027-01-28
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.